Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May support vasomotion-targeted therapies in IHD; leaves open confirmation in prospective trials.
Hiroaki Shimokawa (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: